All News

Patients treated with 12 months of Lixiana, an anticoagulant therapy, received a greater benefit than those treated with three months of the therapy.

A new finding can help predict whether patients with advanced colorectal cancer can benefit from receiving immunotherapy.

The addition of Tumor Treating Fields to standard therapy tended to improve overall survival in patients with pretreated metastatic non-small cell lung cancer.

Healing should be the primary focus of patients and survivors. But for many, the effects of high medical costs can become a burdensome challenge. Care providers, experts and family work to provide assistance.

In honor of Prostate Cancer Awareness Month, we looked back at some of our most viewed and significant prostate cancer content from the summer of 2023.

‘Margaritaville’ singer-songwriter Jimmy Buffett had received a diagnosis of skin cancer followed by lymphoma four years ago, according to TMZ.

I faced cancer thrice and chose life each time — not because of some flowery will to live, but because I’m stubborn and wanted to prove that cancer is not the boss of me.

Here’s a look back at blood cancer approvals from the summer of 2023.

At first, I thought I had hemorrhoids, but ended up eventually being diagnosed with anal cancer.

Here’s a look back at the therapies for solid cancers that gained FDA approval this summer.

Sitting vigil next to an end-of-life patient.

As majority leader Steve Scalise announces his new cancer diagnosis and author Ibram X. Kendi reveals that he is cancer free, this is what’s happening in the oncology space this week.

Survivorship care plans provide survivors of cancer with a multitude of benefits, which in turn, may be empowering.

Balversa has been submitted to the FDA for approval to treat patients with locally advanced or metastatic urothelial carcinoma.

New preoperative and postoperative models can help identify those at high risk of breast cancer-related lymphedema following surgery.

Cancer is truly @#%^%# %#*$!, so go ahead and let the anger out!

Researchers found that patients with pancreatic cancer receiving chemotherapy saw worse survival outcomes when taking Ativan, commonly prescribed to treat anxiety. What other mental health options are available?

A two-time breast cancer survivor who was diagnosed with chronic lymphocytic leukemia in 2020 discussed her belief in the power of minimal residual disease testing.

Skipping radiation therapy for patients with a subset of breast cancer offers them a ‘peace of mind,’ an expert stated.

The recent publication of a guideline recommending mindfulness-based interventions highlight how important it is as a tactic to address symptoms of anxiety and depression in patients with cancer.

My experience with multiple surgical procedures for breast cancer showed me just how important it was to have the total support of my husband.

While the recent approval of a Jemperli-based regimen was an exciting advancement in the endometrial cancer space, racial disparities still exist and need to be addressed, and expert said.

The use of Gavreto is shown to be effective and very well-tolerated in patients with metastatic RET fusion-positive NSCLC, according to an expert.

The FDA has granted a priority review for the evaluation of Xtandi as a treatment for patients with non-metastatic castration-sensitive prostate cancer.

With surgical techniques applicable to many stages of kidney cancer, it is important for patients to discuss these options with their cancer team to select the best approach for their disease.

Becoming an advocate after my cancer diagnosis made an impact not only on others, but for myself.

Patients experiencing chemotherapy-related cognitive impairment may forget where they put things or even stop paying their bills, an expert said.

The Food and Drug Administration approved Reblozyl to treat low red blood cell count in patients with very low- to intermediate-risk myelodysplastic syndrome.

It’s been a long road since being diagnosed with melanoma in early 2020.

When asked for recommended treatments for certain types of cancer, ChatGPT missed the mark about one-third of the time, research showed.